Starting Your Journey with Chanarin-Dorfman Syndrome
At a Glance
Chanarin-Dorfman syndrome is a rare inherited disorder caused by ABHD5 variants that lead to fat buildup in cells. Care focuses on protecting the skin barrier, monitoring organs such as the liver, and coordinating specialist support; dietary changes need expert supervision.
Receiving a diagnosis of Chanarin-Dorfman Syndrome (CDS) often brings a mix of relief and overwhelming uncertainty. You may have spent years visiting different specialists, trying various treatments for what appeared to be more common skin conditions, only to find they didn’t quite fit [1].
This page is designed to help you navigate the early days of this diagnosis, explaining what is happening inside the body and validating the unique challenges of living with a condition that few people—including many doctors—have seen before.
Understanding Your Diagnosis
Chanarin-Dorfman Syndrome, also known as Neutral Lipid Storage Disease with Ichthyosis (NLSDI), is an extremely rare genetic condition. Because there are only a limited number of cases documented in medical literature worldwide, it is very likely that your local healthcare team has never encountered it [2][3].
This rarity often leads to a “diagnostic odyssey,” where patients are misdiagnosed for years with more common conditions like pityriasis rubra pilaris (a chronic skin disorder causing reddish-orange patches) or other types of ichthyosis (a group of conditions causing dry, scaly skin) [1][4]. Finding the right answer through genetic testing is a major milestone that allows you to shift from searching for a cause to managing the condition effectively.
The Role of the ABHD5 Gene
To understand CDS, it helps to think of your cells as having a recycling system for fats. This system is governed by a gene called ABHD5.
- The Mutation: CDS is an autosomal recessive disorder, meaning a person must inherit a pathogenic variant (mutation) of the ABHD5 gene from both parents to develop the condition [5].
- The Fat Buildup: In healthy cells, the ABHD5 gene provides instructions for a protein that acts as a co-activator to help break down triglycerides (a type of fat) stored in tiny bubbles called lipid droplets [6][7]. When this gene isn’t working correctly, this breakdown process is impaired, and these droplets begin to pile up inside various cells throughout the body [8].
- The Skin Barrier: In the skin, ABHD5 has an additional job. It helps create the lipids (oils) that form the “mortar” between your skin cells, which acts as a protective barrier [9]. When this process is disrupted, the skin cannot hold onto moisture or protect itself effectively, leading to the scaling and redness characteristic of ichthyosis [10].
Family Planning and Inheritance
Because CDS is autosomal recessive, genetic counseling is an important step. If both parents are carriers of an ABHD5 mutation, there is a 25% chance with each pregnancy that the child will have the condition, a 50% chance they will be a carrier, and a 25% chance they will be unaffected. A genetic counselor can discuss what this means for siblings, your own future children, and the role of carrier testing for relatives.
A Multisystem Condition
While the most visible sign of CDS is the skin, it is a systemic condition, meaning it can affect several parts of the body over time. It is distinct from its “sibling” condition, Neutral Lipid Storage Disease with Myopathy (NLSDM), which primarily affects the muscles and heart and usually does not involve the skin.
In CDS, the timing and severity of symptoms vary significantly from person to person [11]:
- Skin: Most people are born with congenital ichthyosiform erythroderma, which appears as redness and fine white scales over most of the body [1].
- Liver: As fat droplets build up in liver cells (steatosis), the liver may become enlarged. In some cases, this can progress to more serious issues like cirrhosis (scarring) [12][13].
- Muscles: Some people experience mild muscle weakness or a breakdown of muscle tissue (myopathy) [11].
- Senses and Organs: Over time, fat buildup can affect the eyes (leading to cataracts) or the ears (causing sensorineural hearing loss). Doctors may also monitor your thyroid, kidneys, and neurological health, as variable involvement in these areas has been reported [14].
Navigating Rare Disease Care
The emotional weight of a rare diagnosis is significant. It is normal to feel isolated or anxious about the future. Because CDS is so rare, you may find yourself “teaching” your own doctors about the condition.
While there is currently no cure, management focuses on protecting the skin barrier and monitoring the health of internal organs. You may read that specific dietary adjustments—such as restricting certain fats or supplementing with medium-chain triglycerides (MCTs)—may help liver or muscle symptoms. However, these are based on limited case reports and are not a universally established treatment [15][16]. Never start dietary restrictions independently. Restricting fats without supervision can cause dangerous calorie deficits or deficiencies in essential fatty acids and fat-soluble vitamins (A, D, E, K), particularly in growing children. Any dietary changes must be strictly supervised by a metabolic dietitian.
Building a multidisciplinary team is essential. This team often includes:
- Dermatologists to manage skin care.
- Hepatologists (liver specialists) to monitor liver health.
- Genetic Counselors to provide guidance for the family.
- Audiologists and Ophthalmologists for regular hearing and vision screenings.
By connecting with rare disease communities and staying proactive with monitoring, you can take control of your care journey.
Common questions in this guide
What is Chanarin-Dorfman syndrome?
How is Chanarin-Dorfman syndrome diagnosed?
How is Chanarin-Dorfman syndrome passed through families?
What parts of the body can Chanarin-Dorfman syndrome affect?
Which specialists may help manage this condition?
Is there a cure for Chanarin-Dorfman syndrome?
Should I restrict fat in the diet?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Family and inheritance
Could a genetic counselor explain what this inheritance pattern means for my siblings?
Organs to monitor
Which parts of my body, such as the liver, would need regular checks over time?
Diet guidance
Could I ask a metabolic dietitian whether any dietary changes would be appropriate for me?
Get notified when new evidence is published on Neutral lipid storage disease with ichthyosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
A novel mutation of ABHD5 gene in a Chanarin Dorfman patient with unusual dermatological findings.
Eskiocak AH, Missaglia S, Moro L, et al.
Lipids in health and disease 2019; (18(1)):232 doi:10.1186/s12944-019-1181-6.
PMID: 31883530 - 2
Recurrent N209* ABHD5 mutation in two unreported families with Chanarin Dorfman Syndrome.
Tavian D, Durdu M, Angelini C, et al.
European journal of translational myology 2021; (31(2)) doi:10.4081/ejtm.2021.9796.
PMID: 33985321 - 3
Jordans' anomaly in Chanarin-Dorfman syndrome.
Sánchez-Cortés J, Gabaldó-Barrios X
Advances in laboratory medicine 2025; (6(1)):118-121 doi:10.1515/almed-2024-0159.
PMID: 40160390 - 4
Case Report: Chanarin-Dorfman Syndrome: A Novel Homozygous Mutation in ABHD5 Gene in a Chinese Case and Genotype-Phenotype Correlation Analysis.
Liang B, Huang H, Zhang J, et al.
Frontiers in genetics 2022; (13()):847321 doi:10.3389/fgene.2022.847321.
PMID: 35419035 - 5
Maternal Isodisomy of Chromosome 3 Combined with a De Novo Mutation in the ABHD5 Gene Causes Autosomal Recessive Chanarin-Dorfman Syndrome.
Kopp J, Has C, Hotz A, et al.
Genes 2021; (12(8)) doi:10.3390/genes12081164.
PMID: 34440338 - 6
Critical roles for α/β hydrolase domain 5 (ABHD5)/comparative gene identification-58 (CGI-58) at the lipid droplet interface and beyond.
Brown AL, Mark Brown J
Biochimica et biophysica acta. Molecular and cell biology of lipids 2017; (1862(10 Pt B)):1233-1241 doi:10.1016/j.bbalip.2017.07.016.
PMID: 28827091 - 7
CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis.
Yu L, Li Y, Grisé A, Wang H
Advances in experimental medicine and biology 2020; (1276()):197-222 doi:10.1007/978-981-15-6082-8_13.
PMID: 32705602 - 8
ABHD5-A Regulator of Lipid Metabolism Essential for Diverse Cellular Functions.
Schratter M, Lass A, Radner FPW
Metabolites 2022; (12(11)) doi:10.3390/metabo12111015.
PMID: 36355098 - 9
ABHD5 stimulates PNPLA1-mediated ω-O-acylceramide biosynthesis essential for a functional skin permeability barrier.
Kien B, Grond S, Haemmerle G, et al.
Journal of lipid research 2018; (59(12)):2360-2367 doi:10.1194/jlr.M089771.
PMID: 30361410 - 10
Skin Barrier Development Depends on CGI-58 Protein Expression during Late-Stage Keratinocyte Differentiation.
Grond S, Radner FPW, Eichmann TO, et al.
The Journal of investigative dermatology 2017; (137(2)):403-413 doi:10.1016/j.jid.2016.09.025.
PMID: 27725204 - 11
Long-term neuromuscular, cardiac and liver outcomes in an adult man affected with Chanarin-Dorfman syndrome.
Noman K, Tridimas A, Lilleker JB, et al.
Molecular genetics and metabolism reports 2025; (45()):101265 doi:10.1016/j.ymgmr.2025.101265.
PMID: 41127218 - 12
Chanarin-Dorfman Syndrome: A comprehensive review.
Cakmak E, Bagci G
Liver international : official journal of the International Association for the Study of the Liver 2021; (41(5)):905-914 doi:10.1111/liv.14794.
PMID: 33455044 - 13
Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*).
Quelhas da Costa R, Laranjeira F, Duarte Ribeiro I, et al.
GE Portuguese journal of gastroenterology 2022; (29(4)):284-290 doi:10.1159/000517103.
PMID: 35979251 - 14
Thyroid involvement in Chanarin-Dorfman syndrome in adults in the largest series of patients carrying the same founder mutation in ABHD5 gene.
Louhichi N, Bahloul E, Marrakchi S, et al.
Orphanet journal of rare diseases 2019; (14(1)):112 doi:10.1186/s13023-019-1095-4.
PMID: 31118107 - 15
Ichthyosis, cataracts, and motor delay in an infant: A case of Chanarin-Dorfman syndrome.
Luu Y, Pithadia DJ, Teng J, Khuu P
Pediatric dermatology 2023; (40(5)):879-881 doi:10.1111/pde.15258.
PMID: 36709747 - 16
An Adolescent with Chanarin-Dorfman Syndrome Presenting with Ichthyosis and Hepatic Steatosis.
Habash N, Wang Y, Morava E, Ibrahim SH
JPGN reports 2021; (2(4)):e137 doi:10.1097/PG9.0000000000000137.
PMID: 37206464
This page about Chanarin-Dorfman syndrome is for informational purposes only and does not constitute medical advice. Your genetics, dermatology, liver, and metabolic care teams should interpret test results and guide treatment and dietary changes for you or your child.